Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay

Chiara Criscuolo, C. Procaccini, M. C. Meschini, A. Cianflone, R. Carbone, S. Doccini, D. Devos, C. Nesti, I. Vuillaume, M. Pellegrino, A. Filla, G. De Michele, G. Matarese, F. M. Santorelli

Research output: Contribution to journalArticle

Abstract

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease due to mutations in SACS, which encodes sacsin, a protein localized on the mitochondrial surface and possibly involved in mitochondrial dynamics. In view of the possible mitochondrial involvement of sacsin, we investigated mitochondrial activity at functional and molecular level in skin fibroblasts obtained from ARSACS patients. We observed remarkable bioenergetic damage in ARSACS cells, as indicated by reduced basal, adenosine triphosphate (ATP)-linked and maximal mitochondrial respiration rate, and by reduced respiratory chain activities and mitochondrial ATP synthesis. These phenomena were associated with increased reactive oxygen species production and oxidative nuclear DNA damage. Our results suggest that loss of sacsin is associated with oxidative stress and mitochondrial dysfunction, and thus highlight a novel mechanism in the pathogenesis of ARSACS. The involvement of mitochondria and oxidative stress in disease pathogenesis has been described in a number of other neurodegenerative diseases. Therefore, on the basis of our findings, which suggest a potential therapeutic role for antioxidant agents, ARSACS seems to fall within a larger group of disorders.

Original languageEnglish
Pages (from-to)2755-2763
Number of pages9
JournalJournal of Neurology
Volume262
Issue number12
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Neurodegenerative Diseases
Oxidative Stress
Adenosine Triphosphate
Mitochondrial Dynamics
Respiratory Rate
Electron Transport
Energy Metabolism
DNA Damage
Reactive Oxygen Species
Mitochondria
Fibroblasts
Antioxidants
Spastic ataxia Charlevoix-Saguenay type
Skin
Mutation
Proteins
Therapeutics

Keywords

  • ARSACS
  • Mitochondrial dynamics
  • Mitochondrial metabolism
  • SACS
  • Sacsin

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Criscuolo, C., Procaccini, C., Meschini, M. C., Cianflone, A., Carbone, R., Doccini, S., ... Santorelli, F. M. (2015). Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Journal of Neurology, 262(12), 2755-2763. https://doi.org/10.1007/s00415-015-7911-4

Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay. / Criscuolo, Chiara; Procaccini, C.; Meschini, M. C.; Cianflone, A.; Carbone, R.; Doccini, S.; Devos, D.; Nesti, C.; Vuillaume, I.; Pellegrino, M.; Filla, A.; De Michele, G.; Matarese, G.; Santorelli, F. M.

In: Journal of Neurology, Vol. 262, No. 12, 01.12.2015, p. 2755-2763.

Research output: Contribution to journalArticle

Criscuolo, C, Procaccini, C, Meschini, MC, Cianflone, A, Carbone, R, Doccini, S, Devos, D, Nesti, C, Vuillaume, I, Pellegrino, M, Filla, A, De Michele, G, Matarese, G & Santorelli, FM 2015, 'Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay', Journal of Neurology, vol. 262, no. 12, pp. 2755-2763. https://doi.org/10.1007/s00415-015-7911-4
Criscuolo C, Procaccini C, Meschini MC, Cianflone A, Carbone R, Doccini S et al. Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Journal of Neurology. 2015 Dec 1;262(12):2755-2763. https://doi.org/10.1007/s00415-015-7911-4
Criscuolo, Chiara ; Procaccini, C. ; Meschini, M. C. ; Cianflone, A. ; Carbone, R. ; Doccini, S. ; Devos, D. ; Nesti, C. ; Vuillaume, I. ; Pellegrino, M. ; Filla, A. ; De Michele, G. ; Matarese, G. ; Santorelli, F. M. / Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay. In: Journal of Neurology. 2015 ; Vol. 262, No. 12. pp. 2755-2763.
@article{6ee4ec5b16254a15899f9d628b846979,
title = "Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay",
abstract = "Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease due to mutations in SACS, which encodes sacsin, a protein localized on the mitochondrial surface and possibly involved in mitochondrial dynamics. In view of the possible mitochondrial involvement of sacsin, we investigated mitochondrial activity at functional and molecular level in skin fibroblasts obtained from ARSACS patients. We observed remarkable bioenergetic damage in ARSACS cells, as indicated by reduced basal, adenosine triphosphate (ATP)-linked and maximal mitochondrial respiration rate, and by reduced respiratory chain activities and mitochondrial ATP synthesis. These phenomena were associated with increased reactive oxygen species production and oxidative nuclear DNA damage. Our results suggest that loss of sacsin is associated with oxidative stress and mitochondrial dysfunction, and thus highlight a novel mechanism in the pathogenesis of ARSACS. The involvement of mitochondria and oxidative stress in disease pathogenesis has been described in a number of other neurodegenerative diseases. Therefore, on the basis of our findings, which suggest a potential therapeutic role for antioxidant agents, ARSACS seems to fall within a larger group of disorders.",
keywords = "ARSACS, Mitochondrial dynamics, Mitochondrial metabolism, SACS, Sacsin",
author = "Chiara Criscuolo and C. Procaccini and Meschini, {M. C.} and A. Cianflone and R. Carbone and S. Doccini and D. Devos and C. Nesti and I. Vuillaume and M. Pellegrino and A. Filla and {De Michele}, G. and G. Matarese and Santorelli, {F. M.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s00415-015-7911-4",
language = "English",
volume = "262",
pages = "2755--2763",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "12",

}

TY - JOUR

T1 - Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay

AU - Criscuolo, Chiara

AU - Procaccini, C.

AU - Meschini, M. C.

AU - Cianflone, A.

AU - Carbone, R.

AU - Doccini, S.

AU - Devos, D.

AU - Nesti, C.

AU - Vuillaume, I.

AU - Pellegrino, M.

AU - Filla, A.

AU - De Michele, G.

AU - Matarese, G.

AU - Santorelli, F. M.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease due to mutations in SACS, which encodes sacsin, a protein localized on the mitochondrial surface and possibly involved in mitochondrial dynamics. In view of the possible mitochondrial involvement of sacsin, we investigated mitochondrial activity at functional and molecular level in skin fibroblasts obtained from ARSACS patients. We observed remarkable bioenergetic damage in ARSACS cells, as indicated by reduced basal, adenosine triphosphate (ATP)-linked and maximal mitochondrial respiration rate, and by reduced respiratory chain activities and mitochondrial ATP synthesis. These phenomena were associated with increased reactive oxygen species production and oxidative nuclear DNA damage. Our results suggest that loss of sacsin is associated with oxidative stress and mitochondrial dysfunction, and thus highlight a novel mechanism in the pathogenesis of ARSACS. The involvement of mitochondria and oxidative stress in disease pathogenesis has been described in a number of other neurodegenerative diseases. Therefore, on the basis of our findings, which suggest a potential therapeutic role for antioxidant agents, ARSACS seems to fall within a larger group of disorders.

AB - Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease due to mutations in SACS, which encodes sacsin, a protein localized on the mitochondrial surface and possibly involved in mitochondrial dynamics. In view of the possible mitochondrial involvement of sacsin, we investigated mitochondrial activity at functional and molecular level in skin fibroblasts obtained from ARSACS patients. We observed remarkable bioenergetic damage in ARSACS cells, as indicated by reduced basal, adenosine triphosphate (ATP)-linked and maximal mitochondrial respiration rate, and by reduced respiratory chain activities and mitochondrial ATP synthesis. These phenomena were associated with increased reactive oxygen species production and oxidative nuclear DNA damage. Our results suggest that loss of sacsin is associated with oxidative stress and mitochondrial dysfunction, and thus highlight a novel mechanism in the pathogenesis of ARSACS. The involvement of mitochondria and oxidative stress in disease pathogenesis has been described in a number of other neurodegenerative diseases. Therefore, on the basis of our findings, which suggest a potential therapeutic role for antioxidant agents, ARSACS seems to fall within a larger group of disorders.

KW - ARSACS

KW - Mitochondrial dynamics

KW - Mitochondrial metabolism

KW - SACS

KW - Sacsin

UR - http://www.scopus.com/inward/record.url?scp=84947868504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947868504&partnerID=8YFLogxK

U2 - 10.1007/s00415-015-7911-4

DO - 10.1007/s00415-015-7911-4

M3 - Article

C2 - 26530509

AN - SCOPUS:84947868504

VL - 262

SP - 2755

EP - 2763

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 12

ER -